Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
A briefing from Charles Lister, Department of Health, to Lord Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, on Hepatitis C litigation key findings, noted that there were legitimate expectations that surrogate testing and anti-Hepatitis C screening should had been introduced earlier.
Published on:
09 August, 2024
Charles Lister, Department of Health, recommended to Lord Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, that the court judgment in the "A and Others v National Blood Authority" should not be appealed.
Published on:
09 August, 2024
An email from Christine Dora to Mairi Gibson and others indicated that Officials in Scotland were keen on an appeal against the court judgment in "A and Others v National Blood Authority".
Published on:
09 August, 2024
Dr Aileen Keel regarded the Department of Health's decision not to appeal in "A and Others v National Blood Authority" as "lamentable".
Published on:
09 August, 2024
In his letter to Susan Deacon MSP, Minister for Health and Community Care, Philip Hunt, the Parliamentary Under-Secretary of State for Health in the House of Lords, noted the decision of the ministers not to appeal in "A and Others v National Blood Authority", although with some reluctance.
Published on:
09 August, 2024
John Hutton told the Parliament that "as soon as technology became available to render blood products safe, it was introduced."
Published on:
09 August, 2024
A draft speech on Hepatitis C prepared by officials for the Parliament Adjournment Debate asserted that: "The technology to make blood products free from hepatitis C in sufficient quantities to treat all haemophiliacs in the UK was simply not possible prior to 1985. Once it was the NHS introduced it."
Published on:
09 August, 2024
In preparation for a meeting with the Minister of Health, Vicki King sent a draft speech on Hepatitis C for the Adjournment Debate to Jane Colman._
Published on:
09 August, 2024
Carol Grayson wrote to Baroness Andrews pointing out "the whole-blood hepatitis C cases that were won where the judge stated that testing/screening of blood donors for hepatitis C should have been introduced prior to 1991, and that the country should have acted as other European countries did and adopted testing earlier, erring on the side of caution even if there were some false positive test results".
Published on:
09 August, 2024
Richard Gutowski, in his statement to the Inquiry, recognised that the lines to take drafted for the Government relating to donor screening for Hepatitis C could have better reflected the findings of the Court in "A & others [2001] EWHC QB 446".
Published on:
09 August, 2024
A brief by Scottish Executive officials stated, in relation to the introduction of Hepatitis C screening in 1991, that this development was introduced as early as it reasonably could be in the light of the scientific knowledge and technical capabilities at that time.
Published on:
09 August, 2024
An update for the Secretary of State dated 29 March 2005 emphasised that donor screening for Hepatitis C was introduced in the UK in 1991 and the development of this test marked a major advance in microbiological technology, which could not have been implemented before this time.
Published on:
09 August, 2024
The Secretary of State for Health, Lord John Reid, wrote to Andy Kerr, repeating the line regarding introduction of the donor screening for Hepatitis C in the UK in 1991 in the context of the Government's position that a public inquiry was not justified.
Published on:
09 August, 2024
In his written statement to the Inquiry Lord Reid noted that the wording of his letter to Andrew Kerr was based on the briefing received by officials and agreed that the line was 'simply inaccurate'.
Published on:
09 August, 2024
In his oral evidence to the Inquiry, Lord John Reid acknowledged that it was accurate to say that Hepatitis C screening could have been introduced earlier than 1991, although he did not have knowledge of this at the time.
Published on:
09 August, 2024
In her letter to Nick Harvey MP, Caroline Flint, the Parliamentary Under-Secretary of State for Public Health, repeated the line that Hepatitis C Screening could not have been introduced sooner and that a public inquiry was not justified.
Published on:
09 August, 2024
Responding to Carol Grayson, the Department of Health's Customer Service Directorate asserted that donor screening for Hepatitis C "could not have been implemented" before 1991.
Published on:
09 August, 2024
Lord Warner, speaking in the House of Lords, claimed that "the infection of people with hepatitis C was inadvertent. Nothing could have been done at the time with the technology available to assess the blood for that level of infection."
Published on:
09 August, 2024
Caroline Flint, the Parliamentary Under-Secretary of State for Public Health, repeated in a letter to the Haemophilia Society that "Donor screening for hepatitis C was introduced in the UK in 1991 and the development of this test marked a major advance in microbiological technology, which could not have been implemented before this time."
Published on:
09 August, 2024
The press release, related to the the report on self-sufficiency in blood products in England and Wales, stated that "The review based on the available evidence, concludes that clinicians acted in the best interest of their patients in the light of the evidence available at the time. Donor screening for hepatitis C was introduced in the UK in 1991 and the development of this test marked a major advance in technology, which could not have been implemented before this time."
Published on:
09 August, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2248
Page
2249
Page
2250
Page
2251
Current page
2252
Page
2253
Page
2254
Page
2255
Page
2256
…
Next page
Next
Last page
Last